Skip to main content

Table 2 Demographic and clinical data for Chinese patients with active or stable SLE

From: Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus

 

Active SLE

Stable SLE

N

21

25

Age, yr

33.5 ± 14.2**

36.2 ± 12.3

Female, n (%)

19 (90.5)**

23 (92.0)

Male, n (%)

2 (9.5)**

2 (8.0)

ANA (+), n (%)

21 (100)

25 (100)

dsDNA (+), n (%)

14(67)*

6(24)

C3, g/L

0.64 ± 0.41*

0.94 ± 0.35

C4, g/L

0.13 ± 0.11**

0.20 ± 0.13

SLEDAI score

13.9 ± 3.2*

5.4 ± 2.1

  1. Values shown are mean ± SD unless otherwise noted
  2. ANA, anti-nuclear antibody; C, complement; SLEDAI, systemic lupus erythematosus disease activity index
  3. *p < 0.05 compared to stable SLE group
  4. **p > 0.05 compared to stable SLE group